Multaq (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Multaq drug offered from sanofi-aventis U.S. LLC. This Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Dronedarone |
| SUBSTANCE NAME: | DRONEDARONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Multaq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Multaq from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2009-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-4142_63ea5a96-12b8-47be-8977-8c40ff8f5b5f |
| PRODUCT NDC: | 0024-4142 |
| APPLICATION NUMBER: | NDA022425 |
Other DRONEDARONE Pharmaceutical Manufacturers / Labelers:
